Literature DB >> 11576913

Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?

Y Nishizawa1, T Shoji, E Ishimura, M Inaba, H Morii.   

Abstract

Patients with chronic uremia have a substantially elevated risk of death from cardiovascular disease than do the general population. Although uremic and nonuremic groups share some of the risk factors for cardiovascular mortality, such as older age, diabetes, and inflammation, other factors appear to affect cardiovascular mortality in the opposite direction. For example, being overweight and having hyperlipidemia are established risk factors in the general population, whereas lower body mass index and lower plasma cholesterol have been shown to be risk factors for cardiovascular mortality in end-stage renal disease (ESRD). This paradoxical phenomenon is explained by two facts: (1) that malnutrition is a strong predictor of cardiovascular mortality in ESRD and (2) that plasma lipid levels are lowered in malnutrition. However, it is not known whether atherosclerosis is promoted by malnutrition or by low cholesterol level. Because the cardiovascular mortality rate is theoretically the product of event rate and fatality rate after an event, risk factors for cardiovascular mortality could fall into two categories: those raising the event rate and those affecting the fatality rate. Some factors could work both ways. Patients with ESRD show a significant increase in both event rate and fatality rate. Dyslipidemia is an independent factor affecting atherosclerotic arterial wall changes and cardiovascular events in ESRD. Other factors affecting the cardiovascular event rate in ESRD include diabetes and an elevated homocysteine level. In contrast, factors associated with poor survival after an event include diabetes and anemia. Malnutrition could be a factor causing the fatality rate to rise, although there is no direct evidence supporting this possibility. Further studies are needed to show the differential effects of a risk factor on event rate and fatality rate. Patients with ESRD would have a better chance of living longer by better management of the two categories of risk factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576913     DOI: 10.1053/ajkd.2001.27380

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Body mass index and mortality in patients on maintenance hemodialysis: a meta-analysis.

Authors:  Ting Li; Jun Liu; Shuxian An; Yan Dai; Qing Yu
Journal:  Int Urol Nephrol       Date:  2014-02-07       Impact factor: 2.370

Review 3.  Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji
Journal:  Clin Exp Nephrol       Date:  2013-09-27       Impact factor: 2.801

4.  High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.

Authors:  Hyun Ju Kim; Nosratola D Vaziri; Keith Norris; Won Suk An; Yasmir Quiroz; Bernardo Rodriguez-Iturbe
Journal:  Clin Exp Nephrol       Date:  2010-09-07       Impact factor: 2.801

5.  Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients.

Authors:  Paraskevi Tseke; Eirini Grapsa; Kimon Stamatelopoulos; Elisabeth Samouilidou; Athanasios Protogerou; Christos Papamichael; Antonios Laggouranis
Journal:  Int Urol Nephrol       Date:  2006-11-07       Impact factor: 2.370

Review 6.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

Review 7.  Nutritional and anti-inflammatory interventions in chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Stefan D Anker; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

8.  Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature.

Authors:  T Pliakogiannis; L Trpeski; H Taskapan; H Shah; M Ahmad; S Fenton; J Bargman; D Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.266

9.  The association between blood pressure level and serum uric acid concentration in hemodialysis patients.

Authors:  Jamshid Roozbeh; Mohammad-Mahdi Sagheb; Elaheh Vafaie
Journal:  J Nephropathol       Date:  2015-07-01

10.  Does body mass index affect survival and technique failure in patients undergoing peritoneal dialysis?

Authors:  Aydin Unal; Murat Hayri Sipahioglu; Ismail Kocyigit; Ferhan Elmali; Bulent Tokgoz; Oktay Oymak
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.